| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Characterization of lung cancers in patients with BRCA germline variants: A multicenter series
|
Sanchis-Borja, Mateo
|
|
|
173 |
C |
p. 67-70
|
artikel
|
| 2 |
Contents
|
|
|
|
173 |
C |
p. vi-vii
|
artikel
|
| 3 |
Development of an updated, standardized, patient-centered outcome set for lung cancer
|
de Rooij, Belle H.
|
|
|
173 |
C |
p. 5-13
|
artikel
|
| 4 |
Early change in the clearance of pembrolizumab reflects the survival and therapeutic response: A population pharmacokinetic analysis in real-world non-small cell lung cancer patients
|
Ohuchi, Mayu
|
|
|
173 |
C |
p. 35-42
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
173 |
C |
p. iv
|
artikel
|
| 6 |
EGFR mutation prevalence, real-world treatment patterns, and outcomes among patients with resected, early-stage, non-small cell lung cancer in Canada
|
Sara Kuruvilla, M.
|
|
|
173 |
C |
p. 58-66
|
artikel
|
| 7 |
Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)
|
Aguado de la Rosa, Carlos
|
|
|
173 |
C |
p. 83-93
|
artikel
|
| 8 |
Immune cells in mesothelioma microenvironment simplistic marker of response to nivolumab plus ipilimumab?
|
Disselhorst, Maria J.
|
|
|
173 |
C |
p. 49-52
|
artikel
|
| 9 |
Incidental findings in low dose CT lung cancer screening of high-risk smokers: Results from the Manchester lung Health Check pilot
|
Bradley, P.
|
|
|
173 |
C |
p. 1-4
|
artikel
|
| 10 |
Machine learning-based exceptional response prediction of nivolumab monotherapy with circulating microRNAs in non-small cell lung cancer
|
Zhang, Yifan
|
|
|
173 |
C |
p. 107-115
|
artikel
|
| 11 |
Management of cutaneous toxicities under amivantamab (anti MET and anti EGFR bispecific antibody) in patients with metastatic non-small cell lung cancer harboring EGFR Exon20ins: towards a proactive, multidisciplinary approach
|
Basse, Clémence
|
|
|
173 |
C |
p. 116-123
|
artikel
|
| 12 |
Neighborhood disadvantage and lung cancer risk in a national cohort of never smoking Black women
|
Erhunmwunsee, Loretta
|
|
|
173 |
C |
p. 21-27
|
artikel
|
| 13 |
Prevalence and breakdown of non-small cell lung cancer BRAF driver mutations in a large UK cohort
|
Lim, Guan Hui Tricia
|
|
|
173 |
C |
p. 71-74
|
artikel
|
| 14 |
Proposal for multiple new lesions as complement of hyperprogressive disease in NSCLC patients treated with PD-1/PD-L1 immunotherapy
|
Wang, Mengxiao
|
|
|
173 |
C |
p. 28-34
|
artikel
|
| 15 |
Ramucirumab plus atezolizumab in patients with stage IV non-small cell lung cancer previously treated with immune checkpoint inhibitors
|
Herzog, Brett H.
|
|
|
173 |
C |
p. 101-106
|
artikel
|
| 16 |
Rapid intraoperative Ki-67 immunohistochemistry for lung cancer using non-contact alternating current electric field mixing
|
Atari, Maiko
|
|
|
173 |
C |
p. 75-82
|
artikel
|
| 17 |
Role of 18F-FDG PET/CT in the postoperative follow-up in patients with stage I-III NSCLC: A retrospective single-institution study
|
Kaumanns, Anna
|
|
|
173 |
C |
p. 14-20
|
artikel
|
| 18 |
Safety and efficacy of anlotinib in combination with standard chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A multi-center, prospective study (ACTION-2)
|
Zhang, Wei
|
|
|
173 |
C |
p. 43-48
|
artikel
|
| 19 |
Safety of image guided research biopsies in patients with thoracic malignancies
|
Soosman, Steffan K.
|
|
|
173 |
C |
p. 53-57
|
artikel
|
| 20 |
Utilisation of primary care electronic patient records for identification and targeted invitation of individuals to a lung cancer screening programme
|
Dickson, Jennifer L.
|
|
|
173 |
C |
p. 94-100
|
artikel
|
Tijdschrift beschrijving